Form D · Venture Capital Fund

Epsilon Healthcare Innovation Fund II, LP

Washington, DC · CIK 0001948657

Offering snapshot reported Oct 30, 2026 · SEC filing

Reported sold: $17.6M
Investors reported: 25
Minimum accepted: $100K
First sale: Dec 1, 2022

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors27 → 25

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 30, 2026	Amendment	$17,550,000	$0vs Oct 31, 2025	25	SEC filing
Oct 31, 2025	Amendment	$17,550,000	$6,950,000vs Nov 12, 2024	27	SEC filing
Nov 12, 2024	Amendment	$10,600,000	$0vs Nov 13, 2023	15	SEC filing
Nov 13, 2023	Amendment	$10,600,000	No comparison	15	SEC filing
Nov 18, 2022	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Equity, Pooled investment fund, Other
Exemptions: 06b, 3C, 3C.7, 3C.1
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-465330

General Partner discretion to accept different minimum investment amount.

Source: Form D, filed Oct 30, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

EPSILON HEALTHCARE INNOVATION FUND II, LP

Investment adviser: EPSILON HEALTH INVESTORS, LLC

Gross asset value: $19.3M
Beneficial owners: 26
ADV minimum commitment: $100K

Reported in Form ADV on Mar 26, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ADURO ADVISORS, LLC DENVER, Colorado, United States Investor statements: Some (provided to some but not all investors) Related to adviser: No

Custodian JPMORGAN CHASE & CO. NEW YORK, New York, United States Related to adviser: No

Custodian SILICON VALLEY BANK, A DIVISION OF FIRST CITIZENS BANK NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: No
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

Filing source

Form ADV 2083235 · Mar 26, 2026 · Schedule D 7.B.(1), fund 805-7991015873

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Stevens Brady	Executive
Gregory Epstein	Director, Executive
Steven Epstein	Director, Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

1227 25 Th Street Nw Ste 700
Washington, DC, 20037